-
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
van Dijk, M. J., Rab, M. A. E., van Oirschot, B. A., Bos, J., Derichs, C., Rijneveld, A. W., Cnossen, M. H., Nur, E., Biemond, B. J., Bartels, M., Jans, J. J. M., van Solinge, W. W., Schutgens, R. E. G., van Wijk, R. & van Beers, E. J., 26 Dec 2023, In: Blood advances. 7, 24, p. 7539-7550Research output: Contribution to journal › Article › Academic › peer-review
-
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning
Aydin, M., de Leeuw, D. C., Rutten, C. E., Visser, O. J., Tang, M. W., van Roessel, C., Janssen, J. J. W., Biemond, B. J., van de Loosdrecht, A. A., Hazenberg, M. D., Meijer, E. & Nur, E., Nov 2023, In: British journal of haematology. 203, 3, p. 439-445 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation
Admiraal, M., van Daalen, J., Ritt, M. W. J., Dekker, J., van Tuijn, C. F. J., Nur, E., Hollmann, M. W., Hermanns, H., Hermanides, J. & Biemond, B. J., Sept 2023, In: European journal of haematology. 111, 3, p. 382-390 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications